69 related articles for article (PubMed ID: 30015945)
1. Long non‑coding RNA UCA1 promotes papillary thyroid cancer cell proliferation via miR‑204‑mediated BRD4 activation.
Li D; Cui C; Chen J; Hu Z; Wang Y; Hu D
Mol Med Rep; 2018 Sep; 18(3):3059-3067. PubMed ID: 30015945
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.
Li R; Wan T; Qu J; Yu Y; Zheng R
Aging (Albany NY); 2020 Sep; 12(20):20127-20138. PubMed ID: 32910787
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
Sun Y; Shi T; Ma Y; Qin H; Li K
Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
[TBL] [Abstract][Full Text] [Related]
4. Delving into the Role of lncRNAs in Papillary Thyroid Cancer: Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion.
Tous C; Muñoz-Redondo C; Gavilán A; Bravo-Gil N; Baco-Antón F; Navarro-González E; Antiñolo G; Borrego S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338866
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.
Wu S; Zhu J; Jiang T; Cui T; Zuo Q; Zheng G; Li G; Zhou J; Chen X
Clin Epigenetics; 2024 Jan; 16(1):10. PubMed ID: 38195623
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein.
Zhang X; Zhang X; Yang G; Wan L; Yin F; Li H; Yin D
Biochem Biophys Res Commun; 2023 Aug; 669():95-102. PubMed ID: 37267865
[TBL] [Abstract][Full Text] [Related]
7. LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway.
Wang X; Zhang Y; Zheng J; Yao C; Lu X
Cancer Immunol Immunother; 2021 Aug; 70(8):2235-2245. PubMed ID: 33486611
[TBL] [Abstract][Full Text] [Related]
8. PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression.
Liu L; Wu F; Zhang X; Li X
Curr Cancer Drug Targets; 2024; 24(2):192-203. PubMed ID: 37403394
[TBL] [Abstract][Full Text] [Related]
9. lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.
An L; Dong K; Chi S; Wei S; Zhang J; Yu Z; Zhang Q; Zhang T; Cheng S; Shi R; Jin Z; Zhou X; Zhao Y; Wang H
Mol Carcinog; 2024 Mar; 63(3):384-399. PubMed ID: 38116886
[TBL] [Abstract][Full Text] [Related]
10. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer.
Ha JH; Radhakrishnan R; Nadhan R; Gomathinayagam R; Jayaraman M; Yan M; Kashyap S; Fung KM; Xu C; Bhattacharya R; Mukherjee P; Isidoro C; Song YS; Dhanasekaran DN
Cancer Lett; 2024 Jun; 591():216891. PubMed ID: 38642607
[TBL] [Abstract][Full Text] [Related]
11. Upregulation and the clinical significance of KCNQ1OT1 and HAGLROS lncRNAs in papillary thyroid cancer: An observational study.
Mutlu Icduygu F; Akgun E; Ozgoz A; Hekimler Ozturk K; Sengul D; Alp E
Medicine (Baltimore); 2023 Jul; 102(29):e34379. PubMed ID: 37478216
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer.
Shi L; Duan R; Sun Z; Jia Q; Wu W; Wang F; Liu J; Zhang H; Xue X
Cell Death Differ; 2023 Jun; 30(6):1517-1532. PubMed ID: 37031273
[TBL] [Abstract][Full Text] [Related]
13. LncRNA UCA1 promotes pancreatic cancer cell migration by regulating mitochondrial dynamics via the MAPK pathway.
Wang H; Ding Y; He Y; Yu Z; Zhou Y; Gong A; Xu M
Arch Biochem Biophys; 2023 Oct; 748():109783. PubMed ID: 37816421
[TBL] [Abstract][Full Text] [Related]
14. UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
Lebrun L; Milowich D; Le Mercier M; Allard J; Van Eycke YR; Roumeguere T; Decaestecker C; Salmon I; Rorive S
Oncol Rep; 2018 Nov; 40(5):2497-2506. PubMed ID: 30226613
[TBL] [Abstract][Full Text] [Related]
15. The Knockdown of
Wang L; Zhang Y; Yang J; Liu L; Yao B; Tian Z; He J
DNA Cell Biol; 2021 Sep; 40(9):1211-1221. PubMed ID: 34283663
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA UCA1 inhibits proliferation and invasion of cervical cancer cells through miR-206 expression.
Yan Q; Tian Y; Hao F
Oncol Res; 2018 Mar; ():. PubMed ID: 29523226
[TBL] [Abstract][Full Text] [Related]
17. Exosomal long non-coding RNA UCA1 functions as growth inhibitor in esophageal cancer.
Zhu Z; Wang H; Pang Y; Hu H; Zhang H; Wang W
Aging (Albany NY); 2020 Oct; 12(20):20523–20539. PubMed ID: 33122449
[TBL] [Abstract][Full Text] [Related]
18. UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer.
Yin JY; Zhou Y; Ding XM; Gong RZ; Zhou Y; Hu HY; Liu Y; Lv XB; Zhang B
Curr Cancer Drug Targets; 2024; 24(2):204-219. PubMed ID: 37076962
[TBL] [Abstract][Full Text] [Related]
19. Metformin Suppresses the Proliferation and Promotes the Apoptosis of Colon Cancer Cells Through Inhibiting the Expression of Long Noncoding RNA-UCA1.
Guo J; Li Y; Duan H; Yuan L
Onco Targets Ther; 2020; 13():4169-4181. PubMed ID: 32523353
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-SLC6A9-5:2: A potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction.
Xiang C; Zhang ML; Zhao QZ; Xie QP; Yan HC; Yu X; Wang P; Wang Y
Oncotarget; 2017 Apr; 8(14):22954-22967. PubMed ID: 28086241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
